摘要:
This invention relates to cyclobutane derivatives represented by the following general formula (IV): wherein B represents a nucleic acid base and R⁴ represents hydrogen atom or a protecting group, which is expectedly useful as an antiviral agent or a carcinostatic agent.
摘要:
This invention relates to a cyclobutane derivative represented by the following general formula (I):
wherein X represents a group represented by the formula
(wherein R¹ represents an alkyl group having 1 to 5 carbon atoms or an aryl-substituted alkyl group wherein the alkyl group has 1 to 5 carbon atoms; R² represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, a protected hydroxyalkyl group having 1 to 5 carbon atoms or a protected carboxyl group; and R³ and R⁴ independently represent each a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, a protected hydroxyalkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or an aryl-substituted alkoxy group wherein the alkoxy group has 1 to 5 carbon atoms; or alternately R³ and R⁴ are bound together to thereby form a 3- to 30-membered carbocyclic or heterocyclic ring); A represents an optionally substituted polymethylene group having 2 to 5 carbon atoms; Y represents an oxygen or a sulfur atom; and Z represents an optionally substituted methylene group or an oxygen or a sulfur atom; which is expected to be useful as reagents, drugs, agricultural chemicals and perfumes as well as an intermediate for the preparation thereof.
摘要翻译:本发明涉及由以下通式(I)表示的环丁烷衍生物:其中X表示由式CHEM表示的基团(其中R 1表示具有1至5个碳原子的烷基或 芳基取代的烷基,其中烷基具有1至5个碳原子; R 2表示氢原子,具有1至5个碳原子的烷基,被保护的具有1至5个碳原子的羟烷基或被保护的羧基 R 3和R 4各自独立地表示氢原子,碳原子数1〜5的烷基,碳原子数1〜5的保护羟烷基,碳原子数1〜5的烷氧基或碳原子数1〜5的烷氧基 芳基取代的烷氧基,其中烷氧基具有1至5个碳原子;或者R 3和R 4交替结合在一起形成3-至30元碳环或杂环); A表示任选取代的具有2至5个碳原子的多亚甲基; Y表示氧或硫原子; Z表示任选取代的亚甲基或氧或硫原子; 预期其可用作试剂,药物,农药和香料以及其制备的中间体。
摘要:
This invention relates to cyclobutane derivatives represented by the following general formula (IV): wherein B represents a nucleic acid base and R⁴ represents hydrogen atom or a protecting group, which is expectedly useful as an antiviral agent or a carcinostatic agent.